CD8+ T cell clones induced by this neopeptide kill AML cell lines and primary human AML cells in vitro and in an in vivo patient-derived murine xenograft (PDX) model, in a CBFβ-SMMHC-specific and HLA-A*40:01-restricted manner [53]. The gene discussed is CD8A; the disease is acute myeloid leukemia.